Related Experiment Video
Updated: Jul 17, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
One, two, three--p53, p63, p73 and chemosensitivity
Martina Müller1, Elisa Schulze Schleithoff, Wolfgang Stremmel
1Department of Internal Medicine IV, Hepatology and Gastroenterology, University of Heidelberg, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany. Martina_Mueller-Schilling@med.uni-heidelberg.de
The p53 family network, including p53, p63, and p73, is crucial in cancer. Aberrant isoforms (DeltaN) promote tumors and drug resistance, offering therapeutic targets.
Area of Science:
- Molecular biology
- Cancer research
- Genetics
Background:
- The p53 protein network, including p53, p63, and p73, is implicated in apoptosis, tumorigenesis, and drug resistance.
- Understanding the roles of p53 family members is vital for targeted cancer therapies.
Purpose of the Study:
- To review the status and interrelationships of p53 family members in human cancer.
- To explore their critical roles in tumor progression and therapeutic response.
Main Methods:
- Literature review up to December 2006.
- Analysis of p53, p63, and p73 gene structure, including promoters and alternative splicing.
- Examination of isoform functions, particularly transactivation (TA) and dominant-negative (DeltaN) forms.
Main Results:
- p53, p63, and p73 generate multiple isoforms via alternative splicing.
- Full-length TA isoforms induce apoptosis, while DeltaN isoforms act as dominant inhibitors.
- Deregulated DeltaN isoforms of p63 and p73 contribute to oncogenesis and chemoresistance.
Conclusions:
- Modulating TAp63/DeltaNp63 and TAp73/DeltaNp73, along with mutant p53, presents a therapeutic strategy for p53-mutated or DeltaN-isoform-overexpressing tumors.
- Targeting DeltaNp63 and DeltaNp73 can enhance tumor therapy response and reduce metastasis.
Related Concept Videos
Abnormal Proliferation
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
Negative Regulator Molecules
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

